XORTX Therapeutics XRTX
NASDAQ XRTX
$1.69 -0.01 (-0.58%)
As of: Sep 30, 2026 · 11:41 AM EDT

XORTX Therapeutics (XRTX) Receivables - Net (2020 - 2026)

Updated

XORTX Therapeutics (XRTX) recorded Receivables - Net of $88,090 in the quarter ended Jun 30, 2026, up 711.1% from $10,860 a year earlier and up 36.3% from the prior quarter.

Analysis

XORTX Therapeutics (XRTX) Receivables - Net (2020 - 2026) Analysis & Trends

As of Dec 31, 2025, XORTX Therapeutics reported Receivables - Net of $80,172, up 354.6% from the prior year.

  • Annual Receivables - Net has a five-year compound annual growth rate of 49.6% (years ended Dec 2020 to Dec 2025).
  • Across earlier years, Receivables - Net came in at $17,637 in the year ended Dec 31, 2024 (-70.9%), $60,711 in the year ended Dec 31, 2023 (-25.7%), $81,752 in the year ended Dec 31, 2022 (+98.8%) and $41,126 in the year ended Dec 31, 2021 (+283.9%).
  • The figure for the quarter ended Jun 30, 2026 is the highest quarterly Receivables - Net since the quarter ended Jun 30, 2022.
  • On a year-over-year basis, Receivables - Net has increased for four consecutive quarters, with growth averaging 145.1% over the last eight quarters.
  • Peak year-over-year performance for Receivables - Net in the last five years was growth of 711.1% in the quarter ended Jun 30, 2026, against a decline of 84.4% in the quarter ended Jun 30, 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $64,633 (quarter ended Mar 31, 2026), $80,172 (quarter ended Dec 31, 2025) and $22,092 (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 XORTX Therapeutics 1.62 Mn -1.68 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 88,090.00
Mar 31, 2026 64,633.00
Dec 31, 2025 80,172.00
Sep 30, 2025 22,092.00
Jun 30, 2025 10,860.00
Mar 31, 2025 17,252.00
Dec 31, 2024 17,637.00
Sep 30, 2024 13,111.00
Jun 30, 2024 22,807.00
Mar 31, 2024 30,883.00
Dec 31, 2023 60,711.00
Sep 30, 2023 68,241.00
Jun 30, 2023 30,414.00
Mar 31, 2023 36,421.00
Dec 31, 2022 81,575.12
Sep 30, 2022 66,358.82
Jun 30, 2022 195,583.19
Mar 31, 2022 122,979.74
Dec 31, 2021 40,887.75
Dec 31, 2020 11,008.00
API Access

XORTX Therapeutics Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=XRTX&period=max&api_key=YOUR_API_KEY